Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-08-07
1999-03-02
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3804
Patent
active
058771468
ABSTRACT:
Administration of low doses of hemoglobin minimizes damage to the myocardium after blockage and significantly reduces reperfusion injury. Hemoglobin exerts a pharmacological effect by increasing perfusion and blocking the molecular events leading to permanent injury following an ischemic episode.
REFERENCES:
Lutz et al., Oxygen Transport to Tissues XII, Edited by J. Piiper et al. Plenum Press, NY 1990. pp. 683-690.
Burhop Kenneth E.
McKenzie Jack E.
Baxter International Inc.
Cebulak Mary C.
Dees Jos,e G.
LandOfFree
Therapeutic use of hemoglobin in the treatment of blood vessel b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of hemoglobin in the treatment of blood vessel b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of hemoglobin in the treatment of blood vessel b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-422910